Volume 361, Issue 9352, Pages (January 2003)

Slides:

Advertisements

Similar presentations

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

Advertisements

Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages (January 2010) DOI:

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis.

Ki67 in breast cancer: prognostic and predictive potential

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

BMI and risk of dementia in two million people over two decades: a retrospective cohort study Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.

Pharmacogenetics and future drug development and delivery

Volume 349, Issue 9057, Pages (April 1997)

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

The benefits and harms of breast cancer screening

Peter T. Simpson, Leonard M. Da Silva, Sunil R. Lakhani Cancer Cell

The electronic future of scientific articles

Paediatric HIV-1 infection

Volume 9, Issue 12, Pages (December 2008)

Long-term effects of hormone replacement therapy

Volume 366, Issue 9486, Pages (August 2005)

A twin with Cushing's disease

Klebsiella pneumoniae liver abscesses

Volume 366, Issue 9499, Pages (November 2005)

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study Matthew Waxman, MD,

Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)

Aspirin in the prevention of cancer – Author's reply

Volume 9, Issue 9, Pages (September 2008)

Cancer survivorship: a local and global issue

Exploring the heart of the human heart

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Gene therapy—where are we?

Non-uraemic calciphylaxis with acral necrosis

SNPs and coronary heart disease – Authors' reply

The Gobi Desert medical kit

Physiological hazards of flight at high altitude

Non-communicable disease priority actions and social inclusion

Organisation of the care of patients with heart failure

Disease and stigma The Lancet Volume 354, (December 1999)

HIV myths should not be resuscitated

Resuscitation at birth and cognition at 8 years of age: a cohort study

Pesticide self-poisoning: thinking outside the box

Volume 390, Issue 10094, Pages (August 2017)

David A. Tuveson, John P. Neoptolemos Cell

Psychological response and survival in breast cancer

Volume 362, Pages s6-s7 (December 2003)

Hemifacial sweating after carotid artery dissection

Blue–black eyes and legs

Volume 152, Issue 1, (January 2013)

Volume 11, Issue 4, Pages (April 2010)

Volume 9, Issue 9, Pages (September 2008)

Confessions of a journal junkie

Volume 379, Issue 9812, Pages (January 2012)

Infant-feeding patterns and HIV-1 transmission

Telling it like it isn't: truth and lies in a post-9/11 world

Thank God for Richard Dawkins?

Low-technology approaches

Archana Roy, MD, Alan Peaceman, MD, Moeun Son, MD, Joe Feinglass, PhD

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

Volume 376, Issue 9734, Pages (July 2010)

Vitamin D status and ill health – Author's reply

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis Chunqing Lin,

Volume 4, Issue 5, Pages (May 2017)

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Steven A Narod The Lancet Volume 349, Issue 9068, (June 1997)

Volume 12, Issue 1, Pages (January 2011)

Erratum The Lancet Oncology Volume 3, Issue 8, (August 2002)

Oldest and most feared disease

Volume 12, Issue 5, Pages (May 2013)

Sickle cell disease: a new era

Volume 148, Issue 1, (January 2012)

Volume 374, Issue 9694, Pages (September 2009)

Presentation transcript:

Volume 361, Issue 9352, Pages 125-129 (January 2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study Dr David L Page, MD, Peggy A Schuyler, RN, William D Dupont, PhD, Roy A Jensen, MD, W Dale Plummer, BS, Jean F Simpson, MD The Lancet Volume 361, Issue 9352, Pages 125-129 (January 2003) DOI: 10.1016/S0140-6736(03)12230-1 Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure Cumulative breast cancer morbidity in women with atypical lobular hyperplasia and without proliferative disease or complex fibroadenoma ALH=atypical lobular hyperplasia; DIALH=ductal involvement with cells of ALH; ADH=atypical ductal hyperplasia; PD=proliferative disease; CFA=complex fibroadenoma The Lancet 2003 361, 125-129DOI: (10.1016/S0140-6736(03)12230-1) Copyright © 2003 Elsevier Ltd Terms and Conditions